BACTERIAL MEDIATED TNF ALPHA GENE SILENCING

RNA interference mediated inactivation of hepatitis B virus in a subject

siRNA target hypoxia-inducible factor 1

siRNA targeting gremlin

Molecular targeting agents

Vivo production of small interfering RNAs that mediate gene silencing

RNAi modulation of the BCR-ABL fusion gene and uses thereof

Hindered ester-based biodegradable linkers for oligonucleotide delivery

System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron

In vivo production of small interfering RNAS that mediate gene silencing

Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Compositions and methods for inhibiting expression of a gene from the JC virus

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Gene fusion targeted therapy

Compositions comprising MIR34 therapeutic agents for treating cancer

Method of Treating Pain by Using Opioids and CAMKIV Inhibitors

Categorization of Microbial Communities

siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof

Compositions and methods for reducing or protecting against delayed graft function (DGF)

High potency siRNAS for reducing the expression of target genes

Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases

Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression

Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer

Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer

Methods to regulate miRNA processing by targeting Lin-28

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE

METHODS OF IDENTIFYING AND USING SNAIL1 INHIBITORY COMPOUNDS IN CHONDRODYSPLASIA TREATMENT AND PREPARATION OF PHARMACEUTICAL COMPOSITIONS

Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation

RNAi inhibition of alpha-ENaC expression

RNAi inhibition of alpha-ENaC expression

AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL

RNAi modulation of APOB and uses thereof

RNA Antagonist Compounds for the Modulation of PCSK9

KRUPPEL-LIKE FACTORS AND FAT REGULATION

VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS

THERAPEUTIC DELIVERY OF INHIBITORY NUCLEIC ACID MOLECULES TO THE RESPIRATORY SYSTEM

THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO

RNAi inhibition of alpha-ENaC expression

RNAi inhibition of alpha-ENaC expression

METHOD FOR ENHANCING SERUM STABILITY AND LOWERING IMMUNE RESPONSE OF SIRNA DOWN-REGULATING GENE EXPRESSION OF HBV OR HCV

Nicked or gapped nucleic acid molecules and uses thereof

Targeted delivery of siRNA

INHIBITORS OF PROGASTRIN-INDUCED REPRESSION OF ICAT FOR TREATING AND/OR PREVENTING COLORECTAL CANCER, ADENOMATOUS POLYPOSIS OR METASTASIS DISPLAYING PROGASTRIN-SECRETING CELLS AND CELLS IN WHICH THE BETA-CATENIN/TCF-MEDIATED TRANSCRIPTIONAL PATHWAY IS CONSTITUTIVELY ACTIVE

Chemotherapeutic methods and compositions

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

APCDD1 inhibitors for treating, diagnosing or detecting cancer

Compositions and methods for inhibiting expression of the HAMP gene

Method of Treating Neurodegenerative Disease

SIDNA AGAINST HEPATITIS C VIRUS (HCV)

ANTI-VIRAL METHODS AND COMPOSITIONS

C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER

INFLUENZA THERAPEUTIC

Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo

INHIBITORS FOR GROWTH HORMONE AND RELATED HORMONES, AND METHODS OF USE THEREOF

DR6 ANTAGONISTS AND USES THEREOF IN TREATING NEUROLOGICAL DISORDERS

TARGETS FOR TUMOR GROWTH INHIBITION

Treating Hepatitis C Virus Infection

Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PTP1B GENES

METHOD FOR PROMOTING THE EXPRESSION OF P53, AND P53 EXPRESSION PROMOTER FOR USE IN THE METHOD

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE

Application of RNA Interference Targeting dhfr Gene, to Cell for Producing Secretory Protein

Screening, diagnosing, treating and prognosis of pathophysiologic status by RNA regulation

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

Compositions and methods for modulating ghrelin-mediated conditions

Modulation of blood brain barrier protein expression

METHODS OF TREATING, DIAGNOSING OR DETECTING CANCER

Pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma

METHOD AND SYSTEM FOR BIASING CELLULAR DEVELOPMENT

SiRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)

Genetic suppression and replacement

RNAi inhibition of alpha-ENaC expression

DELIVERY OF NUCLEIC ACIDS USING CELL-PENETRATING PEPTIDES

Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity

Method of producing recombinant biological products

siRNA-MEDIATED GENE SILENCING WITH VIRAL VECTORS

Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma

METHODS AND COMPOSITIONS TO TREAT ARRHYTHMIAS

E. Coli Mediated Gene Silencing of Beta-Catenin

Methods and compositions for post-transcriptional gene silencing

CELL-BASED RNA INTERFERENCE AND RELATED METHODS AND COMPOSITIONS

EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION

PRIMARY MICRO RNA EXPRESSION CASSETTE

Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA

RNAi modulation of SCAP and therapeutic uses thereof

Methods and compositions for enhancing the efficacy and specificity of RNA silencing

Methods and compositions for enhancing the efficacy and specificity of RNA silencing

Methods and compositions for enhancing the efficacy and specificity of RNA silencing

RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

dsRNA For Treating Viral Infection

Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules

SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX

Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof

dsRNA FOR TREATING VIRAL INFECTION

PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING A DOUBLE STRANDED RNA OLIGONUCLEOTIDE AND ITS USE AS AN ACTIVE PHARMACEUTICAL INGREDIENT IN THE TREATMENT OF ANDROGEN RELATED DISEASES

Therapies for cancer using RLIP76

Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists

METHODS OF USING MEVALONATE DECARBOXYLASE (MVD) ANTAGONISTS

PREVENTIVE/REMEDY FOR CANCER

DRAK2 EXPRESSION IS ASSOCIATED WITH DIABETES

Methods for reducing corneal nerves damage, corneal lymphangiogenesis or immunity to corneal antigens in dry-eye associated ocular surface diseases by IL-1Ra

SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES

Compositions and Methods of Using RNA Interference for Control of Nematodes

Modified iRNA agents

Methods and Compositions Involving miRNAs In Cancer Stem Cells

GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF CANCERS

AMPHIPHILIC NUCLEOTIDE COCHLEATE COMPOSITIONS AND METHODS OF USING THE SAME

Tunable genetic switch for regulating gene expression

Extended dicer substrate agents and methods for the specific inhibition of gene expression

EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION

METHODS AND USES RELATED TO RHBDL4

Double-stranded nucleic acid molecule cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer, and bladder cancer

Enhanced biotherapeutic production using inhibitory RNA

METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES

Therapeutic targeting of interleukins using siRNA in neutral liposomes

METHODS, USES AND COMPOSITIONS FOR MODULATING REPLICATION OF HCV THROUGH THE FARNESOID X RECEPTOR (FXR) ACTIVATION OR INHIBITION

Rna constructs

Apoptosis inducer for cancer cell

RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)

COMPOSITIONS AND METHODS FOR SIRNA INHIBITION OF ANGIOGENESIS

GNAQ targeted dsRNA compositions and methods for inhibiting expression

Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules

Therapeutic uses of inhibitors of RTP801L

RAD 9 AS A DIAGNOSTIC,PROGNOSTIC,AND THERAPEUTIC TOOL FOR PROSTATE CANCER

Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics

Methods for screening modulators of SLC17-type anion transport activity

Individualized cancer therapy

Methods and Compositions for Treating Cancer

RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS

siRNA compositions and methods for potently inhibiting viral infection

Method to inhibit cancer targeting CD24

Treating picornavirus infection by targeting MicroRNA miR-141

Methods and compositions concerning siRNA's as mediators of RNA interference

Production of reprogrammed cells with restored potential

METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TURMORGENICITY

Method for treatment of Huntington's disease through intracranial delivery of sirna

siRNA Kinase and Methods of Use

FXDY5 MODULATORS FOR TREATING, DIAGNOSING, AND DETECTING CANCER

Use of double stranded RNA hairpin duplexes in gene silencing

RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

siRNA targeting BCL2L1

Methods for the treatment of infections and tumors

Methods and Systems for Searching for Regulators of the Fer Protein and for Monitoring the Effects of the Fer Protein

Compositions and methods for selective inhibition of VEGF

Method for producing a transgenic pig using a hyper-methylated transposon

siRNA targeting nucleoporin 62kDa (Nup62)

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis

RNAI THERAPEUTIC FOR RESPIRATORY VIRUS INFECTION

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)

INHIBITION OF GPR4

Prostate cancer-specific alternations in ERG gene expression and detection and treatment methods based on those alterations

BLOCKING OF GENE EXPRESSION IN EUKARYOTIC CELLS

CANCER CELL IDENTIFICATION MARKER AND CANCER CELL PROLIFERATION INHIBITOR

Methods involving aldose reductase inhibitors

Targeting agent for cancer cell or cancer-associated fibroblast

siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)

Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell

siRNA-mediated gene silencing with viral vectors

Alpha-synuclein kinase

Osteoarthritis biomarkers and uses thereof

Development of asthma therapy with rAAV-mediated AMCase shRNA

FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs

Method of treating diabetes

Host cell protein knock-out cells for production of therapeutic proteins

CADHERIN-11-MEDIATED MODULATION OF HAIR GROWTH

RAS-MEDIATED EPIGENETIC SILENCING EFFECTORS AND USES THEREOF

Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation

SINGLE-CHAIN CIRCULAR RNA AND METHOD OF PRODUCING THE SAME

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

DOUBLE-STRANDED OLIGONUCLEOTIDES

Polyvalent RNA-nanoparticle compositions

Pure miRNA Sample Preparation Method

Therapeutic Agent for Neuroblastoma Targeting ARID3b

Compositions and methods for siRNA inhibition of HIF-1 α

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis

Methods for treating and preventing multiple sclerosis

Methods of modulating angiogenesis

METHOD OF TREATING MALIGNANT MESOTHELIOMA

COMPOSITIONS AND METHODS FOR THE INHIBITION OF CRIPTO / GRP78 COMPLEX FORMATION AND SIGNALING

Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof

Methods and materials for determining pain sensitivity and predicting and treating related disorders

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)

Lipid formulations for nucleic acid delivery

Methods of treating cancer using siRNA molecules directed against CD24

Diagnosis and treatment of T-cell acute lymphoblastic leukemia

METHODS AND COMPOSITIONS FOR INVESTIGATION AND TREATMENT OF CANCER USING A G-PROTEIN COUPLED EICOSANOID RECEPTOR

COMPOUNDS AND METHODS FOR PEPTIDE RIBONUCLEIC ACID CONDENSATE PARTICLES FOR RNA THERAPEUTICS

Inhibition of autophagy genes in cancer chemotherapy

Trefoil Factors and Methods of Treating Proliferation Disorders Using Same

Treatment of inflammation using BST2 inhibitor

METHODS AND COMPOSITIONS FOR MODULATING THE MIRNA PATHWAY

Method of using gold nanorods-siRNA complexes

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENES

Polypeptides having feruloyl esterase activity and polynucleotides encoding same

Environment-responding siRNA carrier using disulfide-cross-linked polymeric micelle

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Compositions and methods for inhibiting expression of transthyretin

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

Use of a galectin-1-targeted RNAi-based approach for the treatment of cancer

MODIFICATION OF AMYLOID-BETA LOAD IN NON-BRAIN TISSUE

siRNA targeting beta secretase (BACE)

SiRNA targeting myeloid differentiation primary response gene (88) (MYD88)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

Method for Treating Pain with a Calmodulin Inhibitor

Microrna molecules

Methods for treating hematopoietic malignancies

Compounds and methods for down-regulating Wrap53 protein by RNA interference

MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS

METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES

METHOD OF TREATING AN INFLAMMATORY DISEASE BY DOUBLE STRANDED RIBONUCLEIC ACID

siRNA targeting vascular endothelial growth factor (VEGF)

siRNA targeting connective tissue growth factor (CTGF)

NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOF

Short hairpin RNAs for inhibition of gene expression

Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics

COMBINATION THERAPY

Treatment of apolipoprotein-A1 related diseases by inhibition of natural antisense transcript to apolipoprotein-A1

H19 silencing nucleic acid agents for treating rheumatoid arthritis

Methods of Inhibiting Tumor Cell Aggressiveness Using the Microenvironment of Human Embryonic Stem Cells

NUCLEIC ACID COMPOUNDS FOR INHIBITING GENE EXPRESSION AND USES THEREOF

Photocleavable sense-antisense complex

METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION

GENES INVOLVED IN MITOCHONDRIAL BIOGENESIS

RNAi mediated expression inhibition of a cholinergic protein

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

MicroRNA molecules

NOVEL NUCLEIC ACID

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)

METHODS AND COMPOSITIONS FOR RNAI MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMALS

Compositions and methods for gene silencing

COMPOSITIONS AND METHODS FOR TREATING MYELOSUPPRESSION

SiRNA targeting fructose-1, 6-bisphosphatase 1 (FBP1)

RNA interference tags

ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS

Biomarker specific to brain/nerve or specific to neuronal differentiation

Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression

Methods of Inhibiting Tumor Cell Proliferation with FoxM1 siRNA

Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof

Inhibitor Nucleic Acids

MicroRNA molecules

RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)

Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts

NUCLEIC ACID COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH

Modulation of MLCK-L expression and uses thereof

Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference

Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof

Modification of exosomal components for use as a vaccine

Protein Complex and Uses

Bacteria mediated gene silencing

METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME

METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS

Microrna molecules

MicroRNA molecules

Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts

Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

Method of treating cancer with an RPN2 gene expression inhibitor

siRNA targeting spleen tyrosine kinase

siRNA targeting superoxide dismutase 1 (SOD1)

NUCLEIC ACID CONSTRUCTS AND METHODS FOR SPECIFIC SILENCING OF H19

METHODS FOR SLOWING FAMILIAL ALS DISEASE PROGRESSION

Isoform of bruton's tyrosine kinase (BTK) protein

Genetic transformation of algal and cyanobacteria cells by microporation

METHOD OF EVALUATING ANTIWRINKLE SUBSTANCE AND METHOD OF ASSESSING THE SKIN

COMPOSITIONS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS

Systems and method for configuring display resolution in a terminal server environment

Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

Sensizitation of cancer cells to therapy using siNA targeting genes from the 1p and 19q chromosomal regions

Sequence of dsRNA: ATN-RNA specific for tenascin-C

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

METHODS AND COMPOSITIONS RELATING TO POLYPEPTIDES WITH RNASE III DOMAINS THAT MEDIATE RNA INTERFERENCE

Methods and Compositions related to HIF-1 alpha

Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists

siRNA targeting amyloid beta (A4) precursor protein (APP)

Chemically modified oligonucleotides

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

Compositions and methods for modulating activity of capped small RNAs

Mitochondrial function of prohibitin 2 (PHB2)

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V LEIDEN MUTANT GENE

siRNA targeting proto-oncogene MET

Multi-microRNA methods and compositions

Apoptotic cell-mediated transfection of mammalian cells with interfering RNA

Human androgen receptor alternative splice variants as biomarkers and therapeutic targets

Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation

TARGETING OF ALPHA-1 OR ALPHA-3 SUBUNIT OF NA+, K+-ATPASE IN THE TREATMENT OF PROLIFERATIVE DISEASES

Nematode Control

Treatment of neurodegenerative disease through intracranial delivery of SIRNA

SMALL INTERFERING RNA AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HEPATITIS B COMPRISING THE SAME

Prompt nucleic acid delivery carrier composition

siRNA targeting TIE-2

Composition for treatment of cervix cancer